State of New Jersey Common Pension Fund D
CRSP icon

State of New Jersey Common Pension Fund D’s CRISPR Therapeutics CRSP Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Sell
27,270
-2,043
-7% -$108K 0.01% 1267
2026
Q1 		$1.39M Sell
29,313
-11,025
-27% -$582K 0.01% 1378
2025
Q4 		$2.12M Buy
40,338
+68
+0.2% +$4.07K 0.01% 1260
2025
Q3 		$2.61M Sell
40,270
-9,915
-20% -$569K 0.01% 853
2025
Q2 		$2.44M Buy
50,185
+8,645
+21% +$335K 0.01% 832
2025
Q1 		$1.41M Sell
41,540
-3,152
-7% -$134K 0.01% 1440
2024
Q4 		$1.76M Buy
44,692
+4,351
+11% +$205K 0.01% 1473
2024
Q3 		$1.9M Buy
40,341
+5,803
+17% +$294K 0.01% 1403
2024
Q2 		$1.87M Sell
34,538
-10,217
-23% -$591K 0.01% 1217
2024
Q1 		$3.05M Sell
44,755
-4,110
-8% -$294K 0.01% 1067
2023
Q4 		$3.06M Sell
48,865
-3,039
-6% -$168K 0.01% 986
2023
Q3 		$2.36M Hold
51,904
– – 0.01% 1228
2023
Q2 		$2.91M Hold
51,904
– – 0.01% 948
2023
Q1 		$2.35M Hold
51,904
– – 0.01% 1129
2022
Q4 		$2.11M Buy
51,904
+3,391
+7% +$180K 0.01% 1445
2022
Q3 		$3.17M Hold
48,513
– – 0.01% 796
2022
Q2 		$2.95M Buy
48,513
+3,109
+7% +$183K 0.01% 863
2022
Q1 		$2.85M Buy
45,404
+6,263
+16% +$393K 0.01% 1085
2021
Q4 		$2.97M Buy
39,141
+652
+2% +$57K 0.01% 1127
2021
Q3 		$4.31M Sell
38,489
-45
-0.1% -$5.65K 0.01% 815
2021
Q2 		$6.24M Buy
38,534
+1,928
+5% +$234K 0.02% 654
2021
Q1 		$4.46M Buy
36,606
+2,442
+7% +$369K 0.02% 802
2020
Q4 		$5.23M Sell
34,164
-2,799
-8% -$331K 0.02% 689
2020
Q3 		$3.09M Buy
36,963
+5,959
+19% +$529K 0.01% 870
2020
Q2 		$2.28M Sell
31,004
-8,949
-22% -$523K 0.01% 1166
2020
Q1 		$1.69M Hold
39,953
– – 0.01% 1166
2019
Q4 		$2.43M Buy
+39,953
New +$2.18M 0.01% 1227

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CRSP Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its CRISPR Therapeutics (CRSP) stake by 7% in Q2 2026, selling an estimated $108K and leaving 27,270 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #1267.

State of New Jersey Common Pension Fund D first reported a position in CRSP in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.24M in Q2 2021. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 27,270 shares of CRISPR Therapeutics worth $1.49M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 2,043 CRISPR Therapeutics shares in Q2 2026, an estimated $108K.
  • CRISPR Therapeutics made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1267 holding.
  • State of New Jersey Common Pension Fund D first reported a position in CRISPR Therapeutics in Q4 2019 and has held it in 27 quarters since.
  • State of New Jersey Common Pension Fund D's CRISPR Therapeutics position peaked at $6.24M in Q2 2021.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.